- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02785289
A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Vaginal self-sampling for Human Papillomavirus (HPV) testing has been proposed as an efficient method cover hard-to reach populations in developing countries. While the recent cheap cotton swabs have traditionally been used for deoxyribonucleic acid (DNA) detection, recent studies have questioned their efficacy by reporting the superiority of the more expensive flocked swabs.
The objective of this study is to compare the performance of cotton vs flocked swabs for cellular retrieval and HPV DNA quantification after vaginal self-sampling.
A total of 120 women will be recruited. Inclusion criteria will be as follows: 21 years of age or older, attending the colposcopy clinic, understanding the study procedures and able to comply with the study protocol. Pregnant women, those having previously had a total hysterectomy, and women with ongoing menstruation will be excluded. Each woman will collect two different vaginal self samples: one with the cotton swab and one with the flocked swab. Subsequently, a flow cytometric analysis, as well as a real time PCR analysis and a cytologic evaluation for specimen adequacy will be run on each sample. Agreement between the two methods will be calculated using the kappa statistic (κ).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Geneva, Switzerland, 1205
- Geneva University Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- attending the colposcopy clinic
- accepts voluntarily to take part to the study and signs the informed consent form
Exclusion Criteria:
- pregnancy
- previous hysterectomy
- ongoing menstruations
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Flocked
Patients will perform vaginal cell collection beginning with the flocked swab, followed by the coton swab.
|
Vaginal cell collection will be performed with the two types of indicated swab.
|
Experimental: Coton
Patients will perform vaginal cell collection beginning with the coton swab, followed by the flocked swab.
|
Vaginal cell collection will be performed with the two types of indicated swab.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Flow cytometric analysis
Time Frame: 1 week
|
Number of epithelial cells
|
1 week
|
Real-time PCR analysis
Time Frame: 1 month
|
HPV positivity
|
1 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-00412
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Human Papillomavirus Infection
-
The AlfredMerck Sharp & Dohme LLCCompletedHuman Papillomavirus Infection | Human PapillomavirusAustralia
-
University of North Carolina, Chapel HillCenters for Disease Control and Prevention; American Cancer Society, Inc.; New... and other collaboratorsWithdrawnHuman Papillomavirus InfectionUnited States
-
Merck Sharp & Dohme LLCCompletedHuman Papillomavirus Infection
-
Sanford HealthCompletedHuman Papillomavirus InfectionUnited States
-
GlaxoSmithKlineCompletedHuman Papillomavirus InfectionBahrain
-
Centre Hospitalier Universitaire de BesanconCompletedHuman Papillomavirus InfectionFrance
-
University of ConnecticutCompletedHuman Papillomavirus Infection
-
Indiana UniversityMerck Sharp & Dohme LLCUnknownHuman Papillomavirus InfectionUnited States
-
Gen-Probe, IncorporatedCompletedHuman Papillomavirus InfectionUnited States
-
GlaxoSmithKlineCompletedHuman Papillomavirus Infection
Clinical Trials on Vaginal swab
-
Cairo UniversityCompletedFirst Trimester AbortionEgypt
-
Anne's Day LtdCareggi Hospital; Lindus HealthRecruitingChlamydia | Gonorrhea | Human Papilloma Virus | Bacterial VaginosisUnited Kingdom
-
University of LuebeckRecruitingSexually Transmitted InfectionGermany
-
The University of Texas Health Science Center at...CompletedCandidiasis | Vaginitis | Vaginosis, Bacterial | Vaginal Discharge | TrichomonasUnited States
-
University Hospital, Clermont-FerrandNot yet recruitingPremature Birth | Vaginal FloraFrance
-
Assiut UniversityUnknown
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCesarean Section | Microbiome | Vaginal Seeding | NoseUnited States
-
University Hospital, GhentCenter for Microbial Ecology and Technology - Ghent UniversityCompletedRepeated Implantation Failure | Normal FertileBelgium
-
Erasmus Medical CenterThe Dutch Healthcare AuthorityRecruitingPregnancy Related | Infertility, Female | Subfertility, FemaleNetherlands
-
Mỹ Đức HospitalNot yet recruitingVaginal Microbiome | Recurrent Pregnancy Loss, Not Pregnant